The mechanism of radiotherapy and some anti-tumor drugs involves the activation of reactive oxygen species or DNA damage [28], thus PCMT1 is likely to be associated with radiotherapy resistance and drug resistance. This evidence concerns the gene PCMT1 and neoplasm.